Variant report
Variant | rs7249285 |
---|---|
Chromosome Location | chr19:52025948-52025949 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000268777 | Chromatin interaction |
ENSG00000105492 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10409713 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10410468 | 0.86[AMR][1000 genomes];0.89[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs10419617 | 0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs10853837 | 0.92[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1457098 | 0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1551559 | 0.90[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs2124909 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs2124910 | 0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2168637 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs2290660 | 0.89[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs2305772 | 0.91[AFR][1000 genomes];0.94[AMR][1000 genomes];0.98[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4146202 | 0.91[AFR][1000 genomes];0.94[AMR][1000 genomes];0.98[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4802800 | 0.98[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4802801 | 0.98[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4802807 | 0.92[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7250820 | 0.85[AMR][1000 genomes];0.84[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs7259990 | 0.89[AFR][1000 genomes];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs8100330 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs8100538 | 0.87[AFR][1000 genomes];0.84[AMR][1000 genomes];0.84[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs8101887 | 0.86[ASN][1000 genomes] |
rs897783 | 0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1066308 | chr19:51680133-52103974 | Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
2 | nsv544049 | chr19:51680133-52103974 | Bivalent Enhancer Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
3 | nsv544051 | chr19:51944903-52147459 | Bivalent Enhancer Strong transcription Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
4 | esv2758504 | chr19:51991896-52266700 | Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 542 gene(s) | inside rSNPs | diseases |
5 | esv2758767 | chr19:51991896-52604625 | Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 578 gene(s) | inside rSNPs | diseases |
6 | nsv469584 | chr19:52001381-52151821 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
7 | nsv482654 | chr19:52001381-52151821 | Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs7249285 | SIGLEC12 | cis | Thyroid | GTEx |
rs7249285 | SIGLEC12 | cis | Whole Blood | GTEx |
rs7249285 | SIGLEC12 | cis | Artery Tibial | GTEx |
rs7249285 | SIGLEC12 | cis | lung | GTEx |
rs7249285 | SIGLEC12 | cis | Adipose Subcutaneous | GTEx |
rs7249285 | SIGLEC12 | cis | Esophagus Muscularis | GTEx |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:52023400-52027400 | Weak transcription | K562 | blood |
2 | chr19:52023600-52028600 | Weak transcription | Placenta | Placenta |
3 | chr19:52024800-52034200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr19:52025800-52026400 | Enhancers | Primary B cells from peripheral blood | blood |